Table 2.
N=64 | No prevention group n=27 | Prevention group n=37 | |
---|---|---|---|
Negative DSA n=31 | Positive DSA n=6 | ||
Rituximab | 0 | 31 | 6 |
TPE | 0 | 22 | 6 |
DSA: donor specific antibody, TPE: therapeutic plasma exchange
N=64 | No prevention group n=27 | Prevention group n=37 | |
---|---|---|---|
Negative DSA n=31 | Positive DSA n=6 | ||
Rituximab | 0 | 31 | 6 |
TPE | 0 | 22 | 6 |
DSA: donor specific antibody, TPE: therapeutic plasma exchange